With widespread and effective antiretroviral therapy, the life expectancy in the HIV
population has dramatically improved over the last two decades. Consequently, as patients …

An increased prevalence of insulin resistance, glucose intolerance and diabetes has been
reported in HIV infection in the highly active antiretroviral therapy (HAART) era. This …

HIV associated insulin resistance, lipodistrophy and cardiometabolic syndrome have been
extensively studied and continue to be the scope of much research. There is compelling …

Background. Lipoatrophy and metabolic complications of treatment of human
immunodeficiency virus (HIV) infection may share common associations with adipose tissue …

Background The success of antiretroviral therapy (ART) has led to dramatic changes in
causes of morbidity and mortality in HIV-infected individuals. As chronic disease rates have …

Lipodystrophy (lipo) and metabolic derangements associated with an increased
cardiovascular risk are observed frequently in human immunodeficiency virus (HIV)–infected …

People with HIV infection have metabolic abnormalities that resemble metabolic syndrome
(hypertriglyceridemia, low high-density lipoprotein cholesterol, and insulin resistance) …

Background. The association between the use of highly active antiretroviral therapy
(HAART) and an increased risk of metabolic syndrome and cardiovascular disease remains …

Metabolic complications of antiretroviral therapy in HIV-infected patients include insulin
resistance, diabetes mellitus, dyslipidaemia and lipodystrophy syndrome. Metabolic …

The introduction of antiretroviral therapy (ART) has caused some metabolic problems to
people who suffer from HIV. ART probably is not the sole reason for these metabolic …